CDMO Samsung Biologics CEO Outlines “Multidimensional Growth Plan” at 11th Annual Shareholders Meeting
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), held its 11th Annual General Meeting of Shareholders (AGM) on...